News

Galapagos discontinues Phase II trial

Date: 15/04/2011

Mechelen, Belgium – Galapagos announced today that is has stopped its Phase II clinical trial for GLP0259. It will focus resources on other rheumatoid arthritis programs. Read the full article here.